Satellite Symposium | Patient with R/R CLL—Latin American perspective

The virtual Lymphoma Hub Satellite Symposium, at the European School of Haematology (ESH) ‘2nd How to Diagnose and Treat:...

Satellite Symposium | Patient with R/R CLL—European perspective

The virtual Lymphoma Hub Satellite Symposium, at this year's European School of Haematology (ESH) ‘2nd How to Diagnose and Treat:...

Satellite Symposium | Patient with R/R DLBCL—European perspective

At this year’s European School of Haematology (ESH) ‘2nd How to Diagnose and Treat: Lymphoma’ conference, the Lymphoma Hub hosted a...

Satellite Symposium | Patient with R/R DLBCL—US perspective

At this year’s European School of Haematology (ESH) ‘2nd How to Diagnose and Treat: Lymphoma’ conference, the Lymphoma Hub was proud to host...

A summary of the findings from the final analysis of the phase III INNOVATE trial of ibrutinib in WM

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma...

5-year results of the MURANO phase III trial of venetoclax + rituximab vs bendamustine + rituximab in patients with CLL

During the 62nd American Society of Hematology (ASH) Annual Meeting and...

Final analysis of the iNNOVATE study | Five-year follow-up of ibrutinib plus rituximab versus placebo plus rituximab in WM

During the 62nd American Society of Hematology (ASH) Annual Meeting and...

Is a response-adapted treatment strategy feasible for patients with MCL?

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Mats Jerkeman,...

A summary of the findings from the final analysis of the phase III INNOVATE trial of ibrutinib in WM

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma...

Final analysis of the iNNOVATE study | Five-year follow-up of ibrutinib plus rituximab versus placebo plus rituximab in WM

During the 62nd American Society of Hematology (ASH) Annual Meeting and...

ASH 2019 | Practice-changing abstracts in lymphoma and CLL

The Lymphoma Hub has developed a downloadable resource, which provides an update on the practice-changing abstracts in lymphoma and CLL from...

Educational theme: Mutational profile and treatment of Waldenström’s macroglobulinemia

Over the next month, the Lymphoma Hub will be focusing on a new educational theme: Advances in treating...